Musculo-skeletal disorders, Guidance

Applied filters

COVID-19 Vaccines (1)
- General information and guidance (1)
  - All vaccines: Answers to Questions (1)
Care Setting (1)
- Primary Care (1)
- Trusts (1)
Guidance (95)
- Advanced therapy medicinal products (7)
- Cautions and contraindications (1)
- Dosing (3)
- Immunosuppressives (1)
- Safety in Breastfeeding (69)
- Stability in dosette boxes (58)
- Stability outside the fridge (20)
Medicine (87)
- Abatacept (1)
- Aceclofenac (1)
- Acemetacin (1)
- Adalimumab (1)
- Alendronic acid (1)
- Allopurinol (1)
- Amifampridine (1)
- Anakinra (1)
- Azathioprine (1)
- Baclofen (1)
- Belimumab (1)
- Calcitonin (1)
- Canakinumab (1)
- Capsaicin (1)
- Celecoxib (1)
- Certolizumab pegol (1)
- Chloroquine (1)
- Ciclosporin (1)
- Colchicine (1)
- Collagenase clostridium histolyticum (1)
- Dantrolene (1)
- Denosumab (1)
- Dexamethasone (1)
- Dexibuprofen (1)
- Dexketoprofen (1)
- Diazepam (1)
- Diclofenac potassium (1)
- Diclofenac sodium (1)
- Diclofenac sodium + Misoprostol (1)
- Dronabinol + Cannabidiol (1)
- Eculizumab (1)
- Edrophonium (1)
- Etanercept (1)
- Etidronate disodium (1)
- Etodolac (1)
- Etoricoxib (1)
- Fampridine (1)
- Febuxostat (1)
- Felbinac (1)
- Fenoprofen (1)
- Flurbiprofen (1)
- Glucosamine hydrochloride (1)
- Glucosamine sulfate (1)
- Golimumab (1)
- Hydroxychloroquine (1)
- Ibandronic acid (1)
- Ibuprofen (1)
- Indometacin (1)
- Infliximab (1)
- Kaolin (1)
- Ketoprofen (1)
- Leflunomide (1)
- Mefenamic acid (1)
- Meloxicam (1)
- Methocarbamol (1)
- Methotrexate (2)
- Mexiletine (1)
- Nabumetone (1)
- Naltrexone (1)
- Naproxen (1)
- Naproxen + Esomeprazole (1)
- Neostigmine (2)
- Ofatumumab (1)
- Penicillamine (1)
- Piroxicam (1)
- Piroxicam betadex (1)
- Probenecid (1)
- Pyridostigmine (2)
- Quinine (1)
- Rasburicase (1)
- Risedronate sodium (1)
- Rituximab (1)
- Sodium clodronate (1)
- Sodium cromoglicate (1)
- Sodium picosulfate (1)
- Sulfasalazine (1)
- Sulfinpyrazone (1)
- Sulindac (1)
- Tadalafil (1)
- Tenoxicam (1)
- Teriparatide (1)
- Tiaprofenic acid (1)
- Tizanidine (1)
- Tocilizumab (1)
- Ustekinumab (1)
Planning (42)
- Biosimilars (6)
- New Medicines (34)
  - CCG commissioned new medicines (21)
  - NHS England commissioned new medicines (22)
  - Pre-registration new medicines (UK/EU) (4)
- Patent expiries (27)
Specialty (95)
- Allergy and immunology (3)
- Anaesthesia and pain (27)
- Cancers (10)
- Cardiovascular system disorders (4)
- Diabetes (1)
- Ear, nose and throat disorders (3)
- Endocrine system disorders (7)
- Eyes and vision (7)
- Gastrointestinal disorders (8)
- Haematological disorders (2)
- Infection and infectious diseases (5)
- Mental health and illness (1)
- Musculo-skeletal disorders (95)
- Neurological disorders (4)
- Nutritional and metabolic disorders (1)
- Renal and urologic disorders (1)
- Respiratory disorders (1)
- Skin disorders (9)

SGT-001

5 April 2021dm+d: Unassigned

New Medicines

Bidridistrogene xeboparvovec

2 April 2021dm+d: Unassigned

New Medicines

Using COVID-19 vaccines in patient taking immunosuppressive medicines

22 January 2021National advice and considerations on the use of this vaccine in patients taking immunosuppressive medicines

Delandistrogene moxeparvovec

14 September 2020dm+d: Unassigned

New Medicines

PF-06939926

8 May 2020dm+d: Unassigned

New Medicines

How do you convert an oral pyridostigmine or neostigmine dose to a parenteral neostigmine dose?

23 April 2020This updated Medicines Q&A gives suggested dose conversions from oral pyridostigmine or neostigmine to parenteral neostigmine and includes example dose conversion calculations